Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5280121
Max Phase: Preclinical
Molecular Formula: C59H72N8O9S
Molecular Weight: 1069.34
Associated Items:
ID: ALA5280121
Max Phase: Preclinical
Molecular Formula: C59H72N8O9S
Molecular Weight: 1069.34
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCC(=O)NCCCCCCCCCCC(=O)Nc2cccc(Cc3c(C)c4ccc(Oc5ncccn5)cc4oc3=O)c2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C59H72N8O9S/c1-37-46-25-24-45(75-58-61-29-16-30-62-58)34-49(46)76-57(74)47(37)32-40-17-15-18-43(31-40)65-51(70)19-13-11-9-7-8-10-12-14-28-60-50(69)26-27-52(71)66-54(59(4,5)6)56(73)67-35-44(68)33-48(67)55(72)64-38(2)41-20-22-42(23-21-41)53-39(3)63-36-77-53/h15-18,20-25,29-31,34,36,38,44,48,54,68H,7-14,19,26-28,32-33,35H2,1-6H3,(H,60,69)(H,64,72)(H,65,70)(H,66,71)/t38-,44+,48-,54+/m0/s1
Standard InChI Key: RFYHGFDYLXXYEE-NBABBAIJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1069.34 | Molecular Weight (Monoisotopic): 1068.5143 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P.. (2023) Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells., 14 (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446] |
Source(1):